Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
NASDAQ · US
AI hyperscaler and neocloud selling GPU cloud capacity and managed AI infrastructure for training and inference workloads.
Pure-play public AI cloud provider with large-scale NVIDIA GPU capacity and major AI lab and hyperscaler customers.
Price
$89.22
Change
-0.54 (-0.60%)
Market cap
$48.7B
52w range
$61–$153
Exchange
NASDAQ
Country
US
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Daily close for CoreWeave, Inc.
Download statements, ratios, chart data, and transcript indexes.
Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Operating cash flow, capital expenditures, and free cash flow.
Enterprise value, valuation multiples, returns, yields, and cash conversion.
Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Five years of daily close and volume data powering the company chart.
Available earnings-call transcript dates by fiscal year and quarter.
Strong buy
0
Buy
19
Hold
10
Sell
1
Strong sell
0
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $12.89B | $12.51B - $13.23B | $-4.00 | $-5.60 - $-1.20 | -$3.69B | -$7.08B | -$2.22B | $3.06B | 29 rev / 16 EPS |
| 2027-12-31 | $26.48B | $15.98B - $32.41B | $-1.84 | $-5.50 - $3.62 | -$7.58B | -$14.55B | -$1.06B | $6.28B | 29 rev / 16 EPS |
| 2028-12-31 | $42.00B | $36.55B - $48.85B | $0.64 | $-0.47 - $1.23 | -$12.02B | -$23.07B | $165.4M | $9.96B | 23 rev / 11 EPS |
| 2029-12-31 | $58.69B | $49.64B - $67.14B | $4.99 | $3.99 - $5.92 | -$16.80B | -$32.24B | $2.17B | $13.92B | 11 rev / 4 EPS |
| 2030-12-31 | $83.79B | $70.88B - $95.86B | $14.86 | $11.89 - $17.65 | -$23.99B | -$46.03B | $6.48B | $19.88B | 11 rev / 4 EPS |
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | $3.54B | $3.52B - $3.60B | $-1.24 | $-1.78 - $-0.21 | -$1.01B | -$1.95B | -$680.9M | $840.1M | 21 rev / 13 EPS |
| 2026-12-30 | $4.69B | $3.57B - $4.93B | $-0.64 | $-1.93 - $0.95 | -$1.34B | -$2.58B | -$354.3M | $1.11B | 22 rev / 12 EPS |
| 2027-03-30 | $5.26B | $4.75B - $5.49B | $-0.66 | $-0.69 - $-0.57 | -$1.51B | -$2.89B | -$360.9M | $1.25B | 13 rev / 5 EPS |
| 2027-06-30 | $6.04B | $5.46B - $6.31B | $-0.57 | $-0.60 - $-0.50 | -$1.73B | -$3.32B | -$312.2M | $1.43B | 11 rev / 5 EPS |
| 2027-09-30 | $7.03B | $6.36B - $7.34B | $-0.45 | $-0.48 - $-0.40 | -$2.01B | -$3.86B | -$250.5M | $1.67B | 19 rev / 5 EPS |
| 2027-12-30 | $8.07B | $7.29B - $8.42B | $-0.21 | $-0.22 - $-0.19 | -$2.31B | -$4.43B | -$117.1M | $1.91B | 11 rev / 5 EPS |
| 2028-03-30 | $8.72B | $7.88B - $9.09B | $-0.57 | $-0.61 - $-0.50 | -$2.49B | -$4.79B | -$316.8M | $2.07B | 10 rev / 6 EPS |
| 2028-06-30 | $9.64B | $8.71B - $10.06B | $-0.30 | $-0.32 - $-0.27 | -$2.76B | -$5.30B | -$167.6M | $2.29B | 16 rev / 6 EPS |
| Window | Targets | Average target |
|---|---|---|
| Last month | 15 | $137.13 |
| Last quarter | 17 | $141.12 |
| Last year | 56 | $130.11 |
| All time | 65 | $120.77 |
Sources: TheFly, StreetInsider
| Date | Firm | Action | Previous | New |
|---|---|---|---|---|
| 2026-08-14 | Citigroup | Maintain | Buy | Buy |
| 2026-08-13 | Barclays | Maintain | Equal Weight | Equal Weight |
| 2026-08-12 | Wells Fargo | Maintain | Overweight | Overweight |
| 2026-08-12 | Truist Securities | Maintain | Buy | Buy |
| 2026-08-12 | Piper Sandler | Maintain | Overweight | Overweight |
| 2026-08-12 | Mizuho | Maintain | Neutral | Neutral |
| 2026-08-12 | JP Morgan | Maintain | Neutral | Neutral |
| 2026-08-12 | Cantor Fitzgerald | Maintain | Overweight | Overweight |
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-08-01 | 6 | 21 | 10 | 1 | 1 |
| 2026-07-01 | 5 | 21 | 11 | 1 | 1 |
| 2026-06-01 | 4 | 20 | 11 | 1 | 1 |
| 2026-05-01 | 3 | 20 | 11 | 1 | 1 |
| 2026-04-01 | 3 | 20 | 11 | 1 | 1 |
| 2026-03-01 | 3 | 18 | 12 | 1 | 1 |
| 2026-02-01 | 2 | 16 | 11 | 1 | 0 |
| 2026-01-01 | 2 | 16 | 13 | 1 | 1 |
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $5.13B | $3.68B | 71.7% | $0 | -$46.0M | $2.47B | -$1.17B | $-2.75 |
| FY 2024 | $1.92B | $1.42B | 74.2% | $0 | $324.4M | $480.0M | -$863.4M | $-2.33 |
| FY 2023 | $228.9M | $160.2M | 70.0% | $0 | -$14.5M | -$426.4M | -$593.7M | $-1.47 |
| FY 2022 | $15.8M | $3.7M | 23.4% | $0 | -$22.9M | -$13.9M | -$31.1M | $-0.08 |
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $3.06B | $10.31B | -$7.25B |
| FY 2024 | $2.75B | $8.70B | -$5.95B |
| FY 2023 | $1.83B | $2.94B | -$1.11B |
| FY 2022 | $910,000 | $72.4M | -$71.5M |
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $3.98B | $3.17B | $0 | $38.79B | $49.30B | $29.82B | $25.88B | $45.97B | $3.33B |
| FY 2024 | $1.36B | $425.7M | $0 | $14.50B | $17.83B | $10.62B | $9.26B | $18.25B | -$413.6M |
| FY 2023 | $219.5M | $183.0M | $0 | $3.95B | $4.98B | $2.00B | $1.78B | $5.57B | -$596.6M |
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 71.7% | -0.9% | -22.7% | 0.5x | 0.5x | -35.0% | -0.1% | 11.1x | 23.1x | -23.3% | 0.0% | -182d |
| FY 2024 | 74.2% | 16.9% | -45.1% | 0.4x | 0.4x | 208.8% | 2.1% | 13.3x | 53.0x | -36.8% | 0.0% | -561d |
| FY 2023 | 70.0% | -6.3% | -259.3% | 0.5x | 0.5x | 99.5% | -0.3% | 78.3x | -42.1x | -6.9% | 0.0% | -2126d |
| FY 2022 | 23.4% | -144.5% | -196.2% | 0.0x | 0.0x | 0.0% | 0.0% | 0.0x | 0.0x | -0.4% | 0.0% | 0d |
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | +167.9% | +158.6% | 0.0% | -114.2% | -35.2% | -18.0% | -21.8% | -18.5% | +192.4% | 0.0% | +176.5% | +180.8% |
| FY 2024 | +736.6% | +787.9% | 0.0% | +2344.5% | -45.4% | -58.5% | -436.1% | -195.7% | +520.0% | 0.0% | +258.3% | +431.1% |
| FY 2023 | +1346.3% | +4219.4% | 0.0% | +36.8% | -1811.9% | -1811.6% | -1453.2% | -3964.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| FY 2022 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | -- |
Not available.
No segment history on file.
| Period | Total | UNITED STATES | Non-US |
|---|---|---|---|
| FY 2025 | $5.13B | $4.80B | $330.0M |
2026-11-09EPS est $-1.16
Schwab Network · 2026-08-21
Zacks Investment Research · 2026-08-21